Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
25
Frequently Asked Questions
What is Market Cap of Rallybio Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rallybio Corp market cap is $25.06M.
What is the 52-week high for Rallybio Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rallybio Corp 52 week high is $1.24 as of September 18, 2025.
What is the 52-week low for Rallybio Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rallybio Corp 52 week low is $0.2201 as of September 18, 2025.
What is Rallybio Corp stock price today?
Rallybio Corp stock price today is $0.5685.
What was Rallybio Corp stock price yesterday?
Rallybio Corp stock price yesterday was $0.5998.
What is the PE ratio of Rallybio Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rallybio Corp’s P/E ratio is -0.64.
What is the Price-to-Book ratio of Rallybio Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rallybio Corp P/B ratio is 0.5442.
What is the 50-day moving average of Rallybio Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rallybio Corp 50-day moving average is $0.5315.
